SCHEMBL38652196

SCHEMBL38652196

CC(=O)NCCNC(=O)c1cccc(-c2ccccc2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.59
HDAC2 Q92769 1/20 0.59
HDAC8 Q9BY41 1/20 0.58
EPHX2 P34913 1/20 0.57
NR1H4 Q96RI1 1/20 0.57
CDK4 P11802 1/20 0.55
CCND1 P24385 1/20 0.55
HPGD P15428 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.53
KDM4E B2RXH2 1/20 0.53
ALDH1A1 P00352 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
LMNA P02545 1/20 0.53
POLB P06746 1/20 0.53
CFD P00746 1/20 0.52
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
PPARG P37231 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38652527 0.87 MAP4K4 (0.55) HDAC1HDAC2HPGDSMN1; SMN2KDM4E
SCHEMBL1927120 0.86 L3MBTL1 (0.67) HDAC1HDAC2HDAC8EPHX2NR1H4
SCHEMBL16248437 0.85 LMNA (0.70) HDAC1HDAC2HDAC8EPHX2HPGD
SCHEMBL1925893 0.83 SMN1; SMN2 (0.77) HDAC1HDAC2HDAC8EPHX2NR1H4
SCHEMBL12757516 0.83 HDAC8 (0.60) HDAC1HDAC2HDAC8EPHX2NR1H4
SCHEMBL11675554 0.83 PPARG (0.62) HDAC1HDAC2HDAC8EPHX2NR1H4
SCHEMBL18759318 0.83 CFD (0.61) HDAC1HDAC2HDAC8EPHX2NR1H4
SCHEMBL4439622 0.82 HDAC8 (0.64) HDAC1HDAC2HDAC8EPHX2NR1H4
SCHEMBL1927498 0.82 SMN1; SMN2 (0.76) HDAC1HDAC2HDAC8EPHX2NR1H4
SCHEMBL5663566 0.82 SMN1; SMN2 (0.58) HDAC2EPHX2NR1H4SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122029148-A N-phenyl-3- (2, 5-dioxopyrrolidin-1-yl) propionamide derivatives and similar compounds as DUX4 inhibitors for the treatment of, for example, neuromuscular diseases 阿勒泰治疗公司 2026-05-12 CN disclosed